|
|
|
Summary
of 1997 CPCRA Posters and Presentations
| 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Tornoto, Canada, September 1997 |
El-Sadr W, Luskin-Hawk R, Pulling C, Yurik T, Hafner R, Daily versus Thrice Weekly Trimethoprim-Sulfamethoxazole (TMP/SMX) in the Prevention of P. carinii Pneumonia (PCP) (CPCRA 006). Poster
abstract
Ferrigno L, Miller C, Bartsch G, Rukeyser J, Torres R. Survival and Progression of Disease in HIV-Infected (HIV+) Individuals in Interventional Treatment Studies as Compared to an Observational Cohort. Poster
abstract
| 35th Annual Meeting of the Infectious Diseases Society of America (IDSA), September 1997 |
El-Sadr W, Murphy R, Luskin-Hawk R, Yurik T, Hafner R. Atovaquone (ATV) versus Dapsone (DAP) in the Prevention of P. carinii Pneumonia (PCP) in Patients Intolerant to Trimethoprim and/or Sulfamethoxazole (TMP/SMX) CPCRA 034/ACTG 277. Oral.
abstract
Baxter J, Thompson M, MacArthur R, Markowitz N, Mayers D, LiVolsi M, Makohon L, Dehlinger M. Viral Load and Risk of Specific Opportunistic Infections in Patients with CD4 Counts <300 cells/mm3 Enrolled in CPCRA 036. Poster.
abstract
Thompson M, Perez G, Neaton J, Howard S, Baxter J, Dehlinger M, Mayers D, MacArthur R, Chernoff D. Prognostic Value of Plasma HIV RNA and CD4+ Count for Clinical Endpoints in CPCRA 036. Poster.
abstract
| 2nd Joint Meeting - Society for Clinical Trials and International Society for Clinical Biostatistics, Boston, MA, July 1997 |
DuChene A, Collins G, Walker J, Child C, DePew S. Quality Control Reporting for Multicenter Trials - A Report from the CPCRA. Poster.
abstract
Child C, DePew S, Collins G. Retrospective Descriptive Study of Timeliness of Clinical Events Reporting in a National HIV Community-Based Clinical Trials Network. Oral.
abstract
| ALA/ATS International Conference, San Francisco, CA, May 1997 |
Gordin F, Matts J, Miller C, Brown Jr. L, El-Sadr W. Isoniazid (INH) is Not Effective in Preventing Tuberculosis (TB) in Anergic, High-Risk, HIV-Infected Patients (PTS). Oral.
abstract
| National Conference on Women & HIV, Pasadena, CA, May 1997 |
El-Sadr W, Schuman P, Peng G, Capps L, Neaton J. Predictors of Mucosal Candidiasis Among HIV-Infected Women. Published abstract
abstract
| 7th Annual Meeting of The Society for Healthcare Epidemiology of America (SHEA), St. Louis, MO, April 1997 |
Gordin F, Zahnow K, Matts J, Hillman D, Finley E. A Prospective Study of Purified Protein Derivative (PPD) Conversion Rates Among Health-Care Workers (HCWs) Providing HIV Care - The Final Report. Poster.
abstract
| 2nd International Conference on Nutrition and HIV Infection, Cannes, France, April 1997 |
Gibert C, Collins G, Muurahainen N, Raghavan SS, Wheeler D, Williams B, Madans M, Bartsch G. Body Composition and Frequency of Muscle Building Activities in HIV Infected Men. Poster.
abstract
| 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 22 26, 1997 |
Cohn D, Fisher E, Franchino B, Peng G, Hodges JS, Chesnut J, Child C, Gibert C, El Sadr W, Hafner R, Ropka M, Heifets L, Clotfelter J, Munroe D, Caldwell R, Horsburgh Jr. CR. A prospective, randomized trial of four 3 drug regimens for treatment (Rx) of disseminated MAC disease in AIDS (DM): Excess Mortality associated with high dose clarithromycin (C). Poster.
abstract
Kumi J, Collins G, Saravolatz LD. Does ethnicity influence the efficacy and toxicity of combination versus monotherapy with nucleosides in AIDS patients? Poster.
abstract
Baxter J, Neaton J, Wentworth D, Abrams DI. The use of protease inhibitors in the Community Programs for Clinical Research on AIDS (CPCRA). Poster.
abstract
Besch CL, Morse EV, Simon PM, Hodges JS, Franchino B. Preliminary results of a compliance study with CPCRA 007 combination nucleoside study (NuCombo). Poster.
abstract
Brosgart C, Hillman D, Neaton J, Abrams D, Sherer R. Older age is an independent predictor of death and progression of HIV disease. Poster.
abstract
Telzak E, Chirgwin K, Nelson E, Matts J, Benson CA, Sepkowitz K, Perlman D, El Sadr W. Predictors for multidrug resistant tuberculosis (MDRTB) among HIV infected patients and response to specific MDRTB drug regimens. Poster.
abstract
Abrams DI, Neaton J, Wentworth D, Kumi J, Markowitz N, Perez G, Saravolatz LD, Thompson MA, Baxter J. Patterns of antiretroviral drug use over the past 6 years in patients enrolled in community based clinical trials: The CPCRA experience. Poster.
abstract
|
|
